Xin Liu

Prof. Xin Liu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YCYinxin Cui
Yinxin Cui
XLXin Liu
Xin Liu
SLShufang Li
Shufang Li
LHLimin Hao
Limin Hao
JDJuan Du
Juan Du
JLJike Lu
Jike Lu

1 October 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SLShufang Li
Shufang Li
LHLimin Hao
Limin Hao
QKQiaozhen Kang
Qiaozhen Kang
YCYinxin Cui
Yinxin Cui
HJHui Jiang
Hui Jiang
JLJike Lu
Jike Lu

1 January 2018 in Food Chemistry
Verified
Journal Article
Closed access
DPDan Pan
Dan Pan
DZDong Zhang
Dong Zhang
LHLimin Hao
Limin Hao
SLSongyang Lin
Songyang Lin
QKQiaozhen Kang
Qiaozhen Kang
JLJike Lu
Jike Lu

1 December 2015 in International Immunopharmacology
Verified
Journal Article
Closed access
TWTing Wang
Ting Wang
XLXilong Liu
Xilong Liu
ZJZhenyu Ji
Zhenyu Ji
YMYingli Men
Yingli Men
MDMingxuan Du
Mingxuan Du
QKQiao-Zhen Kang
Qiao-Zhen Kang

1 November 2014 in Cellular Immunology
Verified
Journal Article
Closed access
XLXin Liu
Xin Liu
QZQingqing Zhou
Qingqing Zhou
ZJZhenyu Ji
Zhenyu Ji
GFGuo Fu
Guo Fu
YLYi Li
Yi Li
QKQiao-Zhen Kang
Qiao-Zhen Kang

1 February 2018 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
TWTing Wang
Ting Wang
MDMingxuan Du
Mingxuan Du
ZJZhenyu Ji
Zhenyu Ji
CDCong Ding
Cong Ding
CWChengbo Wang
Chengbo Wang
QKQiao-Zhen Kang
Qiao-Zhen Kang
Recombinant Helicobacter pylori neutrophil-activating protein fused with maltose-binding protein (rMBP-NAP), a potential TLR2 ligand, was reported to possess immunomodulatory effects on in situ tumors in our previous study. In the present work, we attempt to elucidate the effect of rMBP-NAP at the local immune modulation in B16-F10-induced metastatic lung cancer. Our results demonstrated that growth of B16-F10 melanoma metastases in the lung was significantly arrested after rMBP-NAP treatment, along with marked reduction in metastatic lung nodules and significant increase in survival. The treatment induced both local and systemic immune responses, which were associated with higher influx of CD4+/CD8+ T cells and drove toward Th1-like and cytotoxic immune environment. Moreover, rMBP-NAP also showed significant anti-angiogenic activity by reducing vascularization in lung tumor sections. rMBP-NAP could induce antitumor immunity through activating Th1 cells and producing pro-inflammatory cytokines, which are responsible for the effective cytotoxic immune response against cancer progression. Our findings indicate that rMBP-NAP might be a novel antitumor therapeutic strategy.